Drug Type Monoclonal antibody |
Synonyms PA 1241, PA1241 |
Target |
Action antagonists |
Mechanism CDH17 antagonists(Cadherin-17 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic breast cancer | Preclinical | Spain | 30 Jan 2022 | |
| Metastatic Colorectal Carcinoma | Preclinical | Spain | 30 Jan 2022 | |
| Metastatic melanoma | Preclinical | Spain | 30 Jan 2022 |






